Published in Am J Obstet Gynecol on December 01, 1992
Polycystic ovary syndrome and its developmental origins. Rev Endocr Metab Disord (2007) 1.61
Effect of bilateral oophorectomy on adrenocortical function in women with polycystic ovary syndrome. Fertil Steril (2012) 1.45
Visually scoring hirsutism. Hum Reprod Update (2009) 1.21
Insulin and hyperandrogenism in women with polycystic ovary syndrome. J Steroid Biochem Mol Biol (2009) 1.14
Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria. Fertil Steril (2009) 1.10
Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome. Endocr Rev (2015) 1.06
Fetal programming of adrenal androgen excess: lessons from a nonhuman primate model of polycystic ovary syndrome. Endocr Dev (2008) 0.99
Oocyte quality in polycystic ovaries revisited: identification of a particular subgroup of women. J Assist Reprod Genet (1997) 0.99
Cardiometabolic aspects of polycystic ovarian syndrome. Vasc Health Risk Manag (2007) 0.93
Adrenal hyperandrogenism is induced by fetal androgen excess in a rhesus monkey model of polycystic ovary syndrome. J Clin Endocrinol Metab (2005) 0.93
Hirsutism: common clinical problem or index of serious disease? MedGenMed (2004) 0.92
Polycystic ovary syndrome: current status and future perspective. Front Biosci (Elite Ed) (2014) 0.86
Nonhuman primates as models for human adrenal androgen production: function and dysfunction. Rev Endocr Metab Disord (2009) 0.85
Obesity differentially affects phenotypes of polycystic ovary syndrome. Int J Endocrinol (2012) 0.85
The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocr Rev (2016) 0.83
Effects of hyperandrogenemia and increased adiposity on reproductive and metabolic parameters in young adult female monkeys. Am J Physiol Endocrinol Metab (2014) 0.83
Regulation of adiponectin secretion by adipocytes in the polycystic ovary syndrome: role of tumor necrosis factor-{alpha}. J Clin Endocrinol Metab (2010) 0.83
Prevalence and clinical predictors of insulin resistance in reproductive-aged thai women with polycystic ovary syndrome. Int J Endocrinol (2012) 0.82
Hirsutism and body mass index in a representative sample of Iranian people. ARYA Atheroscler (2012) 0.81
Uterine perfusion and hormonal pattern in patients with polycystic ovary syndrome. J Assist Reprod Genet (2001) 0.80
Influence of race/ethnicity on cardiovascular risk factors in polycystic ovary syndrome, the Dallas Heart Study. Clin Endocrinol (Oxf) (2015) 0.79
Increased clearance of cortisol by 5beta-reductase in a subgroup of women with adrenal hyperandrogenism in polycystic ovary syndrome. J Endocrinol Invest (2009) 0.78
Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare. Reprod Biol Endocrinol (2012) 0.78
Brachial-to-ankle pulse wave velocity as an independent prognostic factor for ovulatory response to clomiphene citrate in women with polycystic ovary syndrome. J Ovarian Res (2014) 0.77
High Intake of Energy and Fat in Southwest Chinese Women with PCOS: A Population-Based Case-Control Study. PLoS One (2015) 0.77
Is insulin resistance an intrinsic defect in asian polycystic ovary syndrome? Yonsei Med J (2013) 0.77
The changing role of the clinical laboratory in the investigation of polycystic ovarian syndrome. Clin Biochem Rev (2007) 0.77
Effects of drospirenone pill in Indian women with polycystic ovary syndrome. J Turk Ger Gynecol Assoc (2011) 0.75
Assessment of growth and metabolism characteristics in offspring of dehydroepiandrosterone-induced polycystic ovary syndrome adults. Reproduction (2016) 0.75
Roles of Oxidative Stress in Polycystic Ovary Syndrome and Cancers. Oxid Med Cell Longev (2015) 0.75
Effects of metformin on pregnancy outcomes in women with polycystic ovary syndrome: A meta-analysis. Medicine (Baltimore) (2016) 0.75
Ovarian Volume in Korean Women with Polycystic Ovary Syndrome and Its Related Factors. J Menopausal Med (2017) 0.75
Follicle-stimulating hormone receptor gene polymorphism in chronic anovulatory women, with or without polycystic ovary syndrome: a cross-sectional study. Reprod Biol Endocrinol (2014) 0.75
Overexpression of Lnk in the Ovaries Is Involved in Insulin Resistance in Women With Polycystic Ovary Syndrome. Endocrinology (2016) 0.75
Endocrine evaluation of hirsutism. Int J Womens Dermatol (2017) 0.75
Association of ethnicity, Fitzpatrick skin type, and hirsutism: A retrospective cross-sectional study of women with polycystic ovarian syndrome. Int J Womens Dermatol (2017) 0.75
Reproductive and metabolic features during puberty in sons of women with polycystic ovary syndrome. Endocr Connect (2017) 0.75
Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest (1999) 7.69
A novel class of evolutionarily conserved genes defined by piwi are essential for stem cell self-renewal. Genes Dev (1998) 6.74
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst (2003) 6.20
Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry (2001) 4.37
Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry (2001) 4.13
Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA (1995) 4.02
T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. Science (1995) 3.87
c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest (2001) 3.86
Pregnancy after age 50: application of oocyte donation to women after natural menopause. Lancet (1993) 3.60
Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci (2001) 3.46
Does prayer influence the success of in vitro fertilization-embryo transfer? Report of a masked, randomized trial. J Reprod Med (2001) 3.29
Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2001) 3.03
Characterization of a Rous sarcoma virus mutant defective in packaging its own genomic RNA: biochemical properties of mutant TK15 and mutant-induced transformants. J Virol (1984) 2.95
High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype. Arch Neurol (1998) 2.77
JNK2 and IKKbeta are required for activating the innate response to viral infection. Immunity (1999) 2.74
Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Aliment Pharmacol Ther (2005) 2.71
Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol (1995) 2.62
Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2. Mech Dev (1999) 2.56
Isolation and characterization of new fission yeast cytokinesis mutants. Genetics (1998) 2.51
Serum hormones and the alcohol-breast cancer association in postmenopausal women. J Natl Cancer Inst (2001) 2.43
Reversing the natural decline in human fertility. An extended clinical trial of oocyte donation to women of advanced reproductive age. JAMA (1992) 2.29
Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study. Neurology (2000) 2.26
V. Stress and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol (2001) 2.19
Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double-blind, placebo-controlled trials. Aliment Pharmacol Ther (2014) 2.17
Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodies. J Neurochem (2001) 2.14
Prostate cancer risk and serum levels of insulin and leptin: a population-based study. J Natl Cancer Inst (2001) 2.12
Stroke prevention and oestrogen replacement therapy. Lancet (1989) 2.05
Prospective comparison treatment of 595-nm pulsed-dye lasers for virgin port-wine stain. Br J Dermatol (2015) 1.96
Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric (2013) 1.94
Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome. Gastroenterology (1997) 1.94
Aromatase and breast cancer susceptibility. Endocr Relat Cancer (1999) 1.89
Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women. J Natl Cancer Inst (1999) 1.85
Characterization of a Rous sarcoma virus mutant defective in packaging its own genomic RNA: biological properties of mutant TK15 and mutant-induced transformants. J Virol (1984) 1.83
Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders. Aliment Pharmacol Ther (2012) 1.79
Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease. Neurology (1997) 1.78
5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet (1992) 1.77
Association of the human NPPS gene with ossification of the posterior longitudinal ligament of the spine (OPLL). Hum Genet (1999) 1.77
Lower diffusion in white matter of children with prenatal methamphetamine exposure. Neurology (2009) 1.76
The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale. Aliment Pharmacol Ther (2004) 1.76
A preliminary report on oocyte donation extending reproductive potential to women over 40. N Engl J Med (1990) 1.76
Observation of the intrinsic pinning of a magnetic domain wall in a ferromagnetic nanowire. Nat Mater (2011) 1.76
Global consensus statement on menopausal hormone therapy. Climacteric (2013) 1.74
Proportion of reflux esophagitis in 6010 Japanese adults: prospective evaluation by endoscopy. J Gastroenterol (1999) 1.66
Comparison of pharmacodynamic properties of various estrogen formulations. Am J Obstet Gynecol (1982) 1.66
Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Circulation (1998) 1.65
Efficient enzymatic hydrolysis of polyprenyl pyrophosphates. Biochim Biophys Acta (1982) 1.65
Unusual appearances of uterine leiomyomas: MR imaging findings and their histopathologic backgrounds. Radiographics (1999) 1.64
Factors affecting embryo implantation after human in vitro fertilization: a hypothesis. Am J Obstet Gynecol (1990) 1.64
Cerebral activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation. Psychosom Med (2001) 1.64
Characterization of newly emerging Newcastle disease virus isolates from the People's Republic of China and Taiwan. J Clin Microbiol (2001) 1.63
Review article: the treatment of functional abdominal bloating and distension. Aliment Pharmacol Ther (2011) 1.63
The role of the sid1p kinase and cdc14p in regulating the onset of cytokinesis in fission yeast. EMBO J (2000) 1.62
Menopausal hot flushes and night sweats: where are we now? Climacteric (2011) 1.61
Abnormal brain activation on functional MRI in cognitively asymptomatic HIV patients. Neurology (2002) 1.61
Diagnosis and management of a tuberculous, tuboappendiceal fistula. Am J Obstet Gynecol (1988) 1.60
fMRI-acoustic noise alters brain activation during working memory tasks. Neuroimage (2005) 1.60
Crystal structure of cis-prenyl chain elongating enzyme, undecaprenyl diphosphate synthase. Proc Natl Acad Sci U S A (2001) 1.60
Functional GI disorders: from animal models to drug development. Gut (2007) 1.55
Effects of a dual inhibitor of tumor necrosis factor-alpha and interleukin-1 on lipopolysaccharide-induced lung injury in rats: involvement of the p38 mitogen-activated protein kinase pathway. Crit Care Med (2001) 1.55
Characterization of symptoms in irritable bowel syndrome with mixed bowel habit pattern. Neurogastroenterol Motil (2013) 1.55
Impact of congenital narrowing of the bulbar urethra (Cobb's collar) and its transurethral incision in children. Eur Urol (1999) 1.54
Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers. Am J Psychiatry (2001) 1.52
The route of administration influences the effect of estrogen on insulin sensitivity in postmenopausal women. Fertil Steril (1994) 1.51
Why delay the obvious need for milder forms of ovarian stimulation? Hum Reprod (1997) 1.50
Prostate tumor progression is mediated by a paracrine TGF-beta/Wnt3a signaling axis. Oncogene (2008) 1.50
Identification of conserved, RpoS-dependent stationary-phase genes of Escherichia coli. J Bacteriol (1998) 1.49
Brain areas specific for attentional load in a motion-tracking task. J Cogn Neurosci (2001) 1.48
Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric (2011) 1.47
Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). J Cardiovasc Transl Res (2009) 1.47
Gender-related differences in IBS symptoms. Am J Gastroenterol (2001) 1.47
In vivo 1H MRS choline: correlation with in vitro chemistry/histology. Life Sci (1996) 1.46
Severity in irritable bowel syndrome: a Rome Foundation Working Team report. Am J Gastroenterol (2011) 1.46
Autoantibodies in systemic vasculitis. Aust N Z J Med (1991) 1.44
A beta-tubulin leucine cluster involved in microtubule assembly and paclitaxel resistance. J Biol Chem (1999) 1.43
Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies. Lancet Oncol (2013) 1.43
Pregnancy in women 50 or more years of age: outcomes of 22 consecutively established pregnancies from oocyte donation. Fertil Steril (1995) 1.42
Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab (1999) 1.42
Practice-induced changes of brain function during visual attention: a parametric fMRI study at 4 Tesla. Neuroimage (2004) 1.42
Therapeutic controversy: Estrogen replacement in menopause. J Clin Endocrinol Metab (1996) 1.41
Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication. J Viral Hepat (2006) 1.39
Simultaneous establishment of pregnancies in two ovarian failure patients using one oocyte donor. Fertil Steril (1989) 1.39
Formation of regular packets of Staphylococcus aureus cells. J Bacteriol (1977) 1.39
Structure of a cytotoxic T-lymphocyte-specific gene shows a strong homology to fibrinogen beta and gamma chains. Proc Natl Acad Sci U S A (1987) 1.38
Correlation of symptom criteria with perception thresholds during rectosigmoid distension in irritable bowel syndrome patients. Am J Gastroenterol (2000) 1.38
Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations. Cancer Res (1998) 1.38
Embryo implantation after human in vitro fertilization: importance of endometrial receptivity. Fertil Steril (1990) 1.37
Sex specific alterations in autonomic function among patients with irritable bowel syndrome. Gut (2005) 1.37
Fragmented condensate ground state of trapped weakly interacting bosons in two dimensions. Phys Rev Lett (2001) 1.36
A proposed mild type of acute retinal necrosis syndrome. Am J Ophthalmol (1988) 1.35
Progressive right frontotemporal degeneration: clinical, neuropsychological and SPECT characteristics. Dementia (1993) 1.35
Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study. Neurology (2001) 1.35
Gender differences in the functional organization of the brain for working memory. Neuroreport (2000) 1.33
Unusual features of the leader sequence of Rous sarcoma virus packaging mutant TK15. J Virol (1985) 1.32
Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes. J Med Chem (1998) 1.31